Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

featured

Published in Gastroenterology

Journal Scan / Research · March 16, 2021

Rifaximin May Reduce Risk of Overt Hepatic Encephalopathy After TIPS

Annals of Internal Medicine

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Jasmohan Bajaj MBBS, MD, MS

Nikki Duong MD

Mukund Venu MD, FACG

Annals of Internal Medicine

The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: A Randomized Controlled Trial

Ann. Intern. Med 2021 Feb 02;[EPub Ahead of Print], C Bureau, D Thabut, C Jezequel, I Archambeaud, L D'Alteroche, S Dharancy, P Borentain, F Oberti, A Plessier, V De Ledinghen, N Ganne-Carrié, N Carbonell, V Rousseau, A Sommet, JM Péron, JP Vinel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Rifaximin May Reduce Risk of Overt Hepatic Encephalopathy After TIPS

Additional Info

The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: A Randomized Controlled Trial

Further Reading

Small Bowel Microbiome Changes in Individuals With Overweight or Obesity

Increased Risk of Aspiration Pneumonia in GLP-1RA Users Undergoing Endoscopic Procedures

Serum and Urine Metabolomic Profiling in Treatment-Naïve Patients With Newly Diagnosed IBD

Esophageal POEM: Troubleshooting, Managing Adverse Events, and Tips for Success

Role of Liver Stiffness Measurement in Risk Prediction of HCC After HCV Eradication in Veterans With Cirrhosis

Environmental Impact of Gastroenterology and Strategies for Sustainable Practices

Pancreas-Directed AAV8-hSPINK1 Gene Therapy in Mouse Models of Pancreatitis

Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis

Risk Factors and Treatment Strategies for Cholecystitis After Metallic Stent Placement for Malignant Biliary Obstruction

Low Rates of Metastases After Endoscopic Submucosal Dissection of Early Esophageal Adenocarcinoma With Poor Differentiation

Gluten-Free Diet Induces Rapid Changes in Phenotype and Survival Properties of Gluten-Specific T Cells in Celiac Disease

Recently Updated